title: New therapeutic targets in giant-cell arteritis. Considerations based on the current pathogenic model and the availability of new therapeutic agents.
authors.affiliation: Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques, Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Lozano
authors.forename: M
authors.initials: M
authors.lastname: Segarra
authors.forename: A
authors.initials: A
authors.lastname: García-Martínez
authors.forename: G
authors.initials: G
authors.lastname: Espígol-Frigolé
authors.forename: J
authors.initials: J
authors.lastname: Hernández-Rodríguez
authors.forename: M C
authors.initials: MC
authors.lastname: Cid
mesh_terms: D015195:Drug Design; D013700:Giant Cell Arteritis / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D011111:Polymyalgia Rheumatica / Q000188:drug therapy / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
chemical_list: D014409:Tumor Necrosis Factor-alpha